Document is current
Any future updates will be listed below
-
Authors
Holland-Hart, Daniella https://orcid.org/0000-0002-1127-5152
Longo, Mirella https://orcid.org/0000-0002-9867-3806
Bridges, Sarah https://orcid.org/0000-0002-7665-5770
Nixon, Lisette https://orcid.org/0000-0002-1270-6970
Hawkins, Maria https://orcid.org/0000-0002-6669-0628
Crosby, Tom
Nelson, Annmarie https://orcid.org/0000-0002-6075-8425
- License Information
-
More Information
Article History
Received: 23 December 2022
Accepted: 8 February 2025
First Online: 26 February 2025
Declarations
:
: SCOPE2 has full ethical approval from Wales Research Ethics Committee 3 (dated 22nd January 2016, with subsequent approval of each amendment; REC reference 15/WA/0395), and is conducted in accordance with The Medicines for Human Use (Clinical Trials) Regulations 2004 (SI2004/1031) and subsequent amendments, and the Declaration of Helsinki 1996. Written informed consent has been obtained from all study participants, with separate consent obtained for participants in the qualitative interview study.
: Participants consented to the use of anonymised extracts in the study report and publications.
: None declared.
